首页> 外文期刊>Annual Review of Immunology >Interleukin-22: Immunobiology and Pathology
【24h】

Interleukin-22: Immunobiology and Pathology

机译:白介素22:免疫生物学与病理学

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Interleukin-22 (IL-22) is a recently described IL-10 family cytokine that is produced by helper (Th) 17 cells, gamma delta cells, NKT cells, and newly described innate lymphoid cells (ILCs). Knowledge of IL-22 biology has evolved rapidly since its discovery in 2000, and a role for IL-22 has been identified in numerous tissues, including the intestines, lung, liver, kidney, thymus, pancreas. and skin. IL-22 primarily targets nonhematopoietic epithelial and stromal cells, where it can promote proliferation and play a role in tissue regeneration. In addition, IL-22 regulates host defense at barrier surfaces. However, IL-22 has also been linked to several conditions involving inflammatory tissue pathology. In this review, we assess the current understanding of this cytokine, including its physiologic and pathologic effects on epithelial cell function.
机译:白介素-22(IL-22)是最近描述的IL-10家族细胞因子,由辅助(Th)17细胞,γδ细胞,NKT细胞和新近描述的先天淋巴样细胞(ILC)产生。自2000年发现以来,对IL-22生物学的了解迅速发展,并且IL-22在许多组织(包括肠,肺,肝,肾,胸腺,胰腺)中的作用已得到确认。和皮肤。 IL-22主要针对非造血上皮和基质细胞,在其中可以促进增殖并在组织再生中起作用。另外,IL-22调节屏障表面的宿主防御。但是,IL-22也与涉及炎症性组织病理的几种疾病有关。在这篇综述中,我们评估了目前对该细胞因子的了解,包括其对上皮细胞功能的生理和病理影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号